What should be the morning and evening NPH (Novolin N (NPH insulin)) insulin doses and correction scale for a patient with type 2 diabetes mellitus (T2DM) on a norepinephrine (Levophed (norepinephrine)) drip and hydrocortisone (Cortef (hydrocortisone)) 25 mg every 8 hours, with impaired renal function (creatinine 1.14, glomerular filtration rate (GFR) 70), who received continuous renal replacement therapy (CRRT) until yesterday and is scheduled for dialysis today, and has been experiencing hyperglycemia (blood glucose 320-350 mg/dL) despite receiving 30 units of NPH insulin overnight and an additional 17 units of short-acting insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NPH Insulin Dosing for Critically Ill Patient with Steroid-Induced Hyperglycemia

Given this patient's severe hyperglycemia (320-350 mg/dL) despite 30 units NPH plus 17 units short-acting insulin overnight, combined with high-dose glucocorticoids (hydrocortisone 75 mg/day) and vasopressor support, I recommend: AM NPH 40 units, PM NPH 25 units, with an aggressive correction scale of 2 units for every 50 mg/dL above 150 mg/dL.

Rationale for Dose Escalation

  • Current insulin requirements are clearly inadequate: The patient received 47 total units overnight yet remained severely hyperglycemic, indicating significant insulin resistance from multiple factors 1, 2

  • Glucocorticoid effect is substantial: Hydrocortisone 25 mg every 8 hours (75 mg/day total) creates a hyperglycemic pattern peaking in afternoon/evening, requiring 40-60% higher insulin doses than baseline 1, 2

  • Vasopressor-induced insulin resistance: Norepinephrine drips significantly increase insulin requirements through counter-regulatory hormone effects 1

  • Continuous tube feeding with 198g carbohydrate: Using the guideline calculation of 1 unit per 10-15g carbohydrate, this alone requires approximately 13-20 units of nutritional coverage 1, 3

Morning NPH: 40 Units

  • Morning dosing matches steroid pharmacokinetics: Hydrocortisone administered every 8 hours creates peak hyperglycemia during daytime hours, making morning NPH the preferred approach 2, 1

  • Calculation basis: Patient required 47 units overnight with poor control. For steroid-induced hyperglycemia, the morning dose should be higher (approximately 60% of total daily dose) to match the afternoon/evening hyperglycemic peak 2, 3

  • Safety consideration with dialysis: Morning administration allows monitoring during dialysis and reduces risk of undetected hypoglycemia during the procedure 4

Evening NPH: 25 Units

  • Lower evening dose rationale: Overnight insulin sensitivity typically increases, and the steroid effect wanes by late evening 2, 3

  • Renal function consideration: With GFR 70 and recent CRRT discontinuation, insulin clearance may be impaired, increasing hypoglycemia risk overnight 4

  • Approximately 40% of total daily dose: This 40:60 evening-to-morning ratio aligns with steroid-induced hyperglycemia patterns 2

Correction Scale (Aggressive)

Blood glucose 150-200 mg/dL: 2 units
Blood glucose 201-250 mg/dL: 4 units
Blood glucose 251-300 mg/dL: 6 units
Blood glucose 301-350 mg/dL: 8 units
Blood glucose >350 mg/dL: 10 units and notify physician 3, 1

  • Rationale for aggressive scale: Standard correction scales (1 unit per 50 mg/dL) are insufficient given this patient's demonstrated insulin resistance 3

  • Frequency: Administer corrections every 4 hours with rapid-acting insulin (preferred) or every 6 hours with regular insulin 1, 3

Critical Monitoring Protocol

  • Check blood glucose every 2-4 hours during the first 24-48 hours after dose adjustment to identify patterns 2, 3

  • Target range: 140-180 mg/dL for critically ill patients (less stringent than outpatient targets) 1

  • Hypoglycemia protocol: If glucose <70 mg/dL occurs, reduce the corresponding NPH dose by 10-20% immediately 2, 4

  • Dialysis day precautions: Monitor glucose hourly during dialysis, as glucose removal during treatment may precipitate hypoglycemia 4

Adjustment Algorithm for Next 48-72 Hours

  • If fasting glucose remains >180 mg/dL after 3 days: Increase morning NPH by 4 units (given severity of hyperglycemia, use 4-unit increments rather than standard 2-unit increments) 2, 3

  • If afternoon/evening glucose >180 mg/dL: Increase morning NPH by 4 units (as morning NPH peaks 4-6 hours post-administration) 2

  • If overnight glucose >180 mg/dL: Increase evening NPH by 2-4 units 2, 3

  • If requiring >10 units correction insulin daily: Add 50% of total daily correction insulin to scheduled NPH doses 1, 3

Special Considerations for This Patient

  • Tube feeding interruption risk: If tube feeding stops, immediately start 10% dextrose infusion to prevent hypoglycemia, as NPH continues working 12-18 hours 3, 1

  • Steroid taper planning: When hydrocortisone is reduced, decrease NPH doses by 20% per steroid dose reduction to prevent hypoglycemia 2

  • Vasopressor weaning: As norepinephrine is weaned, insulin requirements will decrease by 20-30%; monitor for improving glucose control 2

  • Renal function fluctuation: With GFR 70 and intermittent dialysis, insulin clearance is unpredictable—err on the side of more frequent monitoring rather than aggressive dosing if uncertainty exists 4

Common Pitfalls to Avoid

  • Do NOT use bedtime NPH in this patient: With impaired renal function and dialysis, bedtime dosing creates unacceptable nocturnal hypoglycemia risk 4, 5

  • Do NOT reduce insulin doses prematurely on dialysis days: Dialysis removes glucose but also creates stress response; maintain scheduled doses unless hypoglycemia occurs 4

  • Do NOT use sliding scale alone: Correction insulin without adequate basal coverage perpetuates hyperglycemia 1, 3

  • Watch for the "rebound" pattern: 84% of patients with severe hypoglycemia had preceding mild hypoglycemia—any glucose <70 mg/dL requires immediate dose reduction 3, 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Steroid-Induced Hyperglycemia with NPH Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

NPH Insulin Dosing for Type 3c Diabetes Patient on Continuous Tube Feeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Insulin Regimen for Patients with Impaired Renal Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Morning versus bedtime isophane insulin in type 2 (non-insulin dependent) diabetes mellitus.

Diabetic medicine : a journal of the British Diabetic Association, 1992

Related Questions

Why is morning administration of NPH (Neutral Protamine Hagedorn) insulin not recommended due to the risk of hypoglycemia?
What should the NPH (Neutral Protamine Hagedorn) insulin dose be for a patient with a 1:10 insulin-to-carbohydrate ratio and a daily carbohydrate intake of 291 grams?
What is the recommended NPH insulin dose, carb correction, and correction scale for a patient with severe impaired renal function, obesity, and steroid use?
What is the initial dosing adjustment for NPH (Neutral Protamine Hagedorn) insulin in a twice-daily regimen for a new patient?
What is the initial insulin dose for a 32-week pregnant patient with hyperglycemia?
What is the best course of action for a child or young adult with Attention Deficit Hyperactivity Disorder (ADHD) who experiences restlessness, agitation, anxiety, and dysphoria after taking their second dose of Ritalin (Methylphenidate) LA 20mg, a week after their first dose?
What is the evidence for Polymyxin B (PolyB) combined with high-dose Sulbactam versus Polymyxin B (PolyB) combined with Minocycline for treating Carbapenem-Resistant Acinetobacter baumannii (CRAB) ventilator-associated pneumonia (VAP) in a critically ill patient?
Do aerobic and anaerobic exercise have different effects on symptoms in children with Attention Deficit Hyperactivity Disorder (ADHD)?
What is the recommended treatment approach for a postmenopausal woman with Hormone Receptor (HR)-positive, node-negative breast cancer and an Oncotype DX (Genomic Test) recurrence score of 16-25?
What is the recommended treatment for a premenopausal female with Hormone Receptor (HR)-positive, node-negative breast cancer and an Oncotype DX (Genomic Test) recurrence score of 16-25?
How do you diagnose congestive heart failure (CHF) and can a brain natriuretic peptide (BNP) test result in a false negative?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.